Related Experiment Video
Updated: May 27, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
Published on: August 29, 2015
Phosphoproteomic studies of receptor tyrosine kinases: future perspectives
1Protein Networks Team, Division of Cancer Biology, Institute of Cancer Research, London SW3 6JB, United Kingdom. paul.huang@icr.ac.uk
Abstract:
In the last decade, large-scale mass spectrometry-based phosphoproteomic studies of receptor tyrosine kinases (RTKs) have generated a compendium of signalling networks that are activated downstream of these receptors. In this article, a brief summary of previous phosphoproteomic studies on epidermal growth factor receptor (EGFR) signalling will be presented together with a perspective on the importance for the field to keep pace with new advances in RTK biology. Using examples drawn primarily from studies on the EGFR, c-Met and Flt3 receptors, areas in RTK biology which will greatly benefit from the power of phosphoproteomics will be discussed, including (a) validating oncogenic RTK mutants identified in cancer genome sequencing efforts, (b) spatial RTK signalling networks and (c) understanding crosstalk and co-activation between members of the RTK superfamily.
Insights
Phosphoproteomics reveals complex receptor tyrosine kinase (RTK) signaling networks. This approach is crucial for understanding RTK mutations, spatial signaling, and crosstalk in cancer biology.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Large-scale phosphoproteomic studies have mapped signaling networks downstream of receptor tyrosine kinases (RTKs).
- Receptor tyrosine kinases play critical roles in cellular signaling and are frequently implicated in cancer.
Purpose of the Study:
- To summarize phosphoproteomic studies of epidermal growth factor receptor (EGFR) signaling.
- To highlight the importance of phosphoproteomics in advancing RTK biology.
- To discuss key areas in RTK biology that can benefit from phosphoproteomic analysis.
Main Methods:
- Mass spectrometry-based phosphoproteomics.
- Analysis of signaling networks activated downstream of RTKs.
- Review of existing literature on EGFR, c-Met, and Flt3 signaling.
Main Results:
- Phosphoproteomics provides a comprehensive view of RTK-activated signaling pathways.
- Studies on EGFR, c-Met, and Flt3 exemplify the utility of phosphoproteomics.
- Identified key areas for future phosphoproteomic investigation in RTK biology.
Conclusions:
- Phosphoproteomics is essential for validating oncogenic RTK mutants.
- This technique aids in elucidating spatial RTK signaling networks.
- Phosphoproteomics is vital for understanding crosstalk and co-activation among RTKs.
Related Concept Videos
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
